SMTL ID : 9h65.1

Steroidal Selective Modulators of FXR with Therapeutic Potential

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.10 Å

Oligo State

hetero-2-2-mer

Ligands

2 x RJC: 1-[(3R)-3-[(3R,4R,5S,6R,7R,8S,9S,10R,13R,14S,17R)-6-ethyl-4-fluoranyl-10,13-dimethyl-3,7-bis(oxidanyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]butyl]-3-(phenylsulfonyl)urea(Non-covalent)

RJC.1: 19 residues within 4Å: Chain A: M.26, T.31, L.48, M.51, A.52, H.55, M.89, F.90, R.92, S.93, I.96, S.106, I.113, Y.122, F.127, Y.130, H.208, M.211, W.215 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:L.48, A:M.51, A:R.92, A:I.96, A:I.96, A:I.113, A:F.127, A:Y.130, A:W.215 Hydrogen bonds: A:T.31, A:R.92, A:S.93, A:Y.122, A:Y.130 RJC.2: 20 residues within 4Å: Chain B: M.26, T.31, L.48, M.51, A.52, H.55, M.89, F.90, R.92, S.93, I.96, F.97, I.113, Y.122, M.126, F.127, Y.130, H.208, M.211, W.215 17 PLIP interactions: 17 interactions with chain B Hydrophobic interactions: B:L.48, B:M.51, B:H.55, B:R.92, B:I.96, B:I.96, B:F.97, B:I.113, B:M.126, B:F.127, B:Y.130, B:W.215 Hydrogen bonds: B:R.92, B:S.93, B:Y.122, B:Y.130, B:H.208

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kydd-Sinclair, D. et al., Structural Basis of Novel Bile Acid-Based Modulators of FXR. J.Mol.Biol. (2025)

Release Date

2025-09-10

Peptides

Bile acid receptor: AB
Nuclear receptor coactivator 2: CD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

Bile acid receptor

Nuclear receptor coactivator 2

Related Entries With Identical Sequence